Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...
HOUSTON and WALTHAM, Mass., April 17, 2025 /PRNewswire/ -- Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated ...
Learn 10 key facts about multiple sclerosis, including symptoms, treatments, diagnosis, and ways to manage the condition and live well.
New research reveals that when gut bacteria closely resemble the myelin sheath that protects nerve fibers, the immune system can become confused and attack both — accelerating multiple sclerosis.
Hosted on MSN
Keeping MS under control: New treatments finally bring hope to Floridians living with multiple sclerosis
Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...
Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...
Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...
Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis.
Please provide your email address to receive an email when new articles are posted on . At week 96, treatment led to significant reductions in all exploratory MS-related biomarkers. Additional ...
The faster patients can be diagnosed with multiple sclerosis, the sooner they can begin taking the powerful medications that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results